
The global market for Sitagliptin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Sitagliptin(CAS:486460-32-6) is an anti-diabetic medication used to treat type 2 diabetes.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sitagliptin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sitagliptin API.
The Sitagliptin API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sitagliptin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sitagliptin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NEWEDGE Overseas
Shodhana Laboratories Pvt. Ltd
Synaptics Labs
Ami Lifesciences Private Limited
Everest Organics Limited
Cadila Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Wockhardt
by Type
Above 98 %
Above 99 %
by Application
Tablets
Others
Production by Region
China
India
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sitagliptin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Sitagliptin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Sitagliptin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Sitagliptin API Market Overview
1.1 Product Definition
1.2 Sitagliptin API by Type
1.2.1 Global Sitagliptin API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Sitagliptin API by Application
1.3.1 Global Sitagliptin API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Sitagliptin API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Sitagliptin API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Sitagliptin API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Sitagliptin API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Sitagliptin API Production Market Share by Manufacturers (2020-2025)
2.2 Global Sitagliptin API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Sitagliptin API, Industry Ranking, 2023 VS 2024
2.4 Global Sitagliptin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Sitagliptin API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Sitagliptin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Sitagliptin API, Product Offered and Application
2.8 Global Key Manufacturers of Sitagliptin API, Date of Enter into This Industry
2.9 Sitagliptin API Market Competitive Situation and Trends
2.9.1 Sitagliptin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Sitagliptin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Sitagliptin API Production by Region
3.1 Global Sitagliptin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Sitagliptin API Production Value by Region (2020-2031)
3.2.1 Global Sitagliptin API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Sitagliptin API by Region (2026-2031)
3.3 Global Sitagliptin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Sitagliptin API Production Volume by Region (2020-2031)
3.4.1 Global Sitagliptin API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Sitagliptin API by Region (2026-2031)
3.5 Global Sitagliptin API Market Price Analysis by Region (2020-2025)
3.6 Global Sitagliptin API Production and Value, Year-over-Year Growth
3.6.1 China Sitagliptin API Production Value Estimates and Forecasts (2020-2031)
3.6.2 India Sitagliptin API Production Value Estimates and Forecasts (2020-2031)
4 Sitagliptin API Consumption by Region
4.1 Global Sitagliptin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Sitagliptin API Consumption by Region (2020-2031)
4.2.1 Global Sitagliptin API Consumption by Region (2020-2025)
4.2.2 Global Sitagliptin API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Sitagliptin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Sitagliptin API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Sitagliptin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Sitagliptin API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Sitagliptin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Sitagliptin API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Sitagliptin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Sitagliptin API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Sitagliptin API Production by Type (2020-2031)
5.1.1 Global Sitagliptin API Production by Type (2020-2025)
5.1.2 Global Sitagliptin API Production by Type (2026-2031)
5.1.3 Global Sitagliptin API Production Market Share by Type (2020-2031)
5.2 Global Sitagliptin API Production Value by Type (2020-2031)
5.2.1 Global Sitagliptin API Production Value by Type (2020-2025)
5.2.2 Global Sitagliptin API Production Value by Type (2026-2031)
5.2.3 Global Sitagliptin API Production Value Market Share by Type (2020-2031)
5.3 Global Sitagliptin API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Sitagliptin API Production by Application (2020-2031)
6.1.1 Global Sitagliptin API Production by Application (2020-2025)
6.1.2 Global Sitagliptin API Production by Application (2026-2031)
6.1.3 Global Sitagliptin API Production Market Share by Application (2020-2031)
6.2 Global Sitagliptin API Production Value by Application (2020-2031)
6.2.1 Global Sitagliptin API Production Value by Application (2020-2025)
6.2.2 Global Sitagliptin API Production Value by Application (2026-2031)
6.2.3 Global Sitagliptin API Production Value Market Share by Application (2020-2031)
6.3 Global Sitagliptin API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 NEWEDGE Overseas
7.1.1 NEWEDGE Overseas Sitagliptin API Company Information
7.1.2 NEWEDGE Overseas Sitagliptin API Product Portfolio
7.1.3 NEWEDGE Overseas Sitagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 NEWEDGE Overseas Main Business and Markets Served
7.1.5 NEWEDGE Overseas Recent Developments/Updates
7.2 Shodhana Laboratories Pvt. Ltd
7.2.1 Shodhana Laboratories Pvt. Ltd Sitagliptin API Company Information
7.2.2 Shodhana Laboratories Pvt. Ltd Sitagliptin API Product Portfolio
7.2.3 Shodhana Laboratories Pvt. Ltd Sitagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Shodhana Laboratories Pvt. Ltd Main Business and Markets Served
7.2.5 Shodhana Laboratories Pvt. Ltd Recent Developments/Updates
7.3 Synaptics Labs
7.3.1 Synaptics Labs Sitagliptin API Company Information
7.3.2 Synaptics Labs Sitagliptin API Product Portfolio
7.3.3 Synaptics Labs Sitagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Synaptics Labs Main Business and Markets Served
7.3.5 Synaptics Labs Recent Developments/Updates
7.4 Ami Lifesciences Private Limited
7.4.1 Ami Lifesciences Private Limited Sitagliptin API Company Information
7.4.2 Ami Lifesciences Private Limited Sitagliptin API Product Portfolio
7.4.3 Ami Lifesciences Private Limited Sitagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Ami Lifesciences Private Limited Main Business and Markets Served
7.4.5 Ami Lifesciences Private Limited Recent Developments/Updates
7.5 Everest Organics Limited
7.5.1 Everest Organics Limited Sitagliptin API Company Information
7.5.2 Everest Organics Limited Sitagliptin API Product Portfolio
7.5.3 Everest Organics Limited Sitagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Everest Organics Limited Main Business and Markets Served
7.5.5 Everest Organics Limited Recent Developments/Updates
7.6 Cadila Pharmaceuticals
7.6.1 Cadila Pharmaceuticals Sitagliptin API Company Information
7.6.2 Cadila Pharmaceuticals Sitagliptin API Product Portfolio
7.6.3 Cadila Pharmaceuticals Sitagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Cadila Pharmaceuticals Main Business and Markets Served
7.6.5 Cadila Pharmaceuticals Recent Developments/Updates
7.7 Zhejiang Huahai Pharmaceutical
7.7.1 Zhejiang Huahai Pharmaceutical Sitagliptin API Company Information
7.7.2 Zhejiang Huahai Pharmaceutical Sitagliptin API Product Portfolio
7.7.3 Zhejiang Huahai Pharmaceutical Sitagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Zhejiang Huahai Pharmaceutical Main Business and Markets Served
7.7.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7.8 Wockhardt
7.8.1 Wockhardt Sitagliptin API Company Information
7.8.2 Wockhardt Sitagliptin API Product Portfolio
7.8.3 Wockhardt Sitagliptin API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Wockhardt Main Business and Markets Served
7.8.5 Wockhardt Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Sitagliptin API Industry Chain Analysis
8.2 Sitagliptin API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Sitagliptin API Production Mode & Process Analysis
8.4 Sitagliptin API Sales and Marketing
8.4.1 Sitagliptin API Sales Channels
8.4.2 Sitagliptin API Distributors
8.5 Sitagliptin API Customer Analysis
9 Sitagliptin API Market Dynamics
9.1 Sitagliptin API Industry Trends
9.2 Sitagliptin API Market Drivers
9.3 Sitagliptin API Market Challenges
9.4 Sitagliptin API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
NEWEDGE Overseas
Shodhana Laboratories Pvt. Ltd
Synaptics Labs
Ami Lifesciences Private Limited
Everest Organics Limited
Cadila Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Wockhardt
Ìý
Ìý
*If Applicable.
